Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.

Biotechnology

Harbour BioMed

Jingsong Wang

Xin Yang

Yingying Chen

Xicao N.

Xiaoxiang Chen

Victor Chen

Qing Wang

Kenny SHEN

Yiping Rong

Weihao Xu

Xiaolu Tao

Research and Development Team

Leadership Team

Clinical Operations Team

Teams at Harbour BioMed

Research and Development Team

Leadership Team

Clinical Operations Team